LENZ Therapeutics, Inc. (LENZ)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$3.96+$0.2400 (+6.45%) on the dayAs of the close; data may be delayed.
LENZ price, last 12 months
Key stats
- Previous close
- $3.72
- Open
- $3.74
- Day range
- $3.66 – $4.00
- 52-week range
- $3.60 – $50.40
- Volume
- 846.2K
- Avg volume (20 days)
- 753.6K
- Market cap
- $123.0M
Performance
1W−2.7%
1M−17.2%
3M−32.0%
6M−55.7%
YTD−75.3%
1Y−90.4%
vs S&P 500, 1Y−107.1 pts
Technicals and fundamentals
About LENZ Therapeutics, Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $123.0M